Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus

BACKGROUND: Soluble suppression of tumorigenesis-2 (sST2) is a strong prognostic biomarker of cardiovascular (CV) disease. End-stage kidney disease (ESKD) patients are at high risk of CV events and infections. Herein we investigated the utility of sST2 to predict all-cause and cause-specific mortali...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer, Fabian, Genser, Bernd, Dieplinger, Benjamin, Egger, Margot, Müller, Thomas, Drechsler, Christiane, März, Winfried, Störk, Stefan, Wanner, Christoph, Krane, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494540/
https://www.ncbi.nlm.nih.gov/pubmed/36158148
http://dx.doi.org/10.1093/ckj/sfac142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494540/
https://www.ncbi.nlm.nih.gov/pubmed/36158148
http://dx.doi.org/10.1093/ckj/sfac142

Ejemplares similares